KPC-2-producing Klebsiella pneumoniae isolated from a Czech patient previously hospitalized in Greece and in vivo selection of colistin resistance
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Anti-Bacterial Agents pharmacology MeSH
- Drug Resistance, Bacterial drug effects genetics MeSH
- beta-Lactamases biosynthesis genetics MeSH
- Hospitalization MeSH
- Klebsiella pneumoniae drug effects enzymology genetics isolation & purification MeSH
- Colistin pharmacology MeSH
- Humans MeSH
- Microbial Sensitivity Tests MeSH
- Porins genetics MeSH
- Gene Expression Regulation, Bacterial MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Greece MeSH
- Names of Substances
- Anti-Bacterial Agents MeSH
- beta-lactamase KPC-2, Klebsiella pneumoniae MeSH Browser
- beta-Lactamases MeSH
- Colistin MeSH
- Porins MeSH
Carbapenemase-producing Gram-negative bacteria peak clinical interest due to their ability to hydrolyze most β-lactams, including carbapenems; moreover, their genes spread through bacterial populations by horizontal transfer. Bacteria with acquired carbapenemase have sporadically been reported in the Czech Republic, so far only in Enterobacteriaceae and Pseudomonas aeruginosa. In this study, we described the first finding of a KPC-2-producing strain of Klebsiella pneumoniae, which was isolated from a surgical wound swab, decubitus ulcer, and urine of a patient previously hospitalized in Greece. The patient underwent various antibiotic therapies including a colistin treatment. However, after approximately 20 days of the colistin therapy, the strain developed a high-level resistance to this drug. All the isolates were indistinguishable by pulsed field gel electrophoretic analysis and belonged to the international clone ST258, which is typical of KPC-producing K. pneumoniae isolates. The bla (KPC-2) gene was located on a Tn4401a transposon variant. The OmpK35 and OmpK36 genes analysis performed due to the high resistance level of the strains to β-lactams exhibited no changes in their sequence or in their expression when compared with carbapenem-susceptible isolates.
See more in PubMed
Nucleic Acids Res. 2002 May 1;30(9):e36 PubMed
Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):765-9 PubMed
Eur J Clin Microbiol Infect Dis. 2010 May;29(5):563-70 PubMed
J Antimicrob Chemother. 2010 Feb;65(2):243-8 PubMed
Antimicrob Agents Chemother. 2000 Jun;44(6):1499-505 PubMed
Antimicrob Agents Chemother. 2009 Oct;53(10):4565-7 PubMed
J Clin Microbiol. 2005 Aug;43(8):4178-82 PubMed
J Hosp Infect. 2010 Sep;76(1):70-3 PubMed
FEMS Microbiol Lett. 2010 Aug 1;309(1):62-70 PubMed
Antimicrob Agents Chemother. 2010 Jul;54(7):3002-6 PubMed
Antimicrob Agents Chemother. 2008 Apr;52(4):1257-63 PubMed
Antimicrob Agents Chemother. 2009 Aug;53(8):3365-70 PubMed
Infection. 1990 Sep-Oct;18(5):294-8 PubMed
J Antimicrob Chemother. 2009 Apr;63(4):654-8 PubMed
Clin Microbiol Infect. 2010 Feb;16(2):112-22 PubMed
Antimicrob Agents Chemother. 2004 Dec;48(12):4793-9 PubMed
J Antimicrob Chemother. 2009 Oct;64(4):718-22 PubMed
Euro Surveill. 2009 Oct 08;14(40): PubMed
J Antimicrob Chemother. 2008 Nov;62(5):978-85 PubMed
Evidence of an epidemic spread of KPC-producing Enterobacterales in Czech hospitals
Characterization of KPC-Encoding Plasmids from Enterobacteriaceae Isolated in a Czech Hospital